NCT01076985 - Special Investigation of Kaletra in Pregnant Women | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

December 31, 2000

Primary Completion Date

December 31, 2010

Study Completion Date

December 31, 2010

Conditions

Human Immunodeficiency Virus

Interventions

DRUG

Lopinavir/ritonavir (Kaletra)

Lopinavir/ritonavir (LPV/r) evaluated separately in patients who were naive to previous antiretroviral treatment and those who were not.

Trial Locations (5)

Site Reference ID/Investigator# 35862, Aichi

Site Reference ID/Investigator# 35863, Okayama

Site Reference ID/Investigator# 35864, Osaka

Site Reference ID/Investigator# 35865, Tokyo

Site Reference ID/Investigator# 5326, Tokyo